StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.42−0.06 (-4.05%)

Close on Nov 17, 2026Market cap $53.14MP/E –Yield –

Tenax Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Tenax Therapeutics's EV/EBITDA was 68.9× on Jan 31, 2024.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 202468.9×−48.5
2023Dec 29, 2023117.3×−692.5
2022Jan 31, 2022809.8×–

More Tenax Therapeutics figures

See a number that looks wrong?